Symbiotic Capital – which starts life with more than $600 million at its disposal, is an affiliate of Bellco Capital, an ...

This approach not only aligns companies with cutting-edge scientific advancements, but also builds investor confidence by ...

Chronic cough impacts up to 10% of the adult population and has a physical, psychological, and social impact on patients’ ...

The solid quarter is important for Bayer as it tries to rebuild under chief executive Bill Anderson, who was brought in to ...

The latest lawsuit brought by the family of Henrietta Lacks, filed in a federal court in Maryland, names Novartis Pharma, ...

An FDA advisory committee has recommended approval of Zevra Therapeutics' arimoclomol for the ultra-rare disorder ...

Ireland-headquartered pharma group Mallinckrodt has agreed to divest its subsidiary Therakos to private equity firm CVC ...

Shares in Actinium Pharmaceuticals have lost almost two-thirds of their value after the FDA asked for a second clinical trial ...

Bristol-Myers Squibb has handed back rights to a TIGIT drug partnered with Agenus, ending an alliance that could have been worth up to $1.56 billion to the biotech.

New results from an ongoing phase 1/2 study of the therapy showed that it was able to slow down disease progression in ...

EVERSANA, a leading provider of global commercial services to the life sciences industry, today introduced TEDAVI, the ...

23andMe went public via a merger with a special purpose acquisition company (SPAC) in 2021 and at one point was valued at ...